StockData
Johnson & Johnson logo

Johnson & Johnson

JNJNYSEPharmaceutical PreparationsFiscal year ends January 3
Financials through Q2 FY2026, quarter ended Jun 28, 2026Last filing: 10-Q on Oct 21, 2026Score 12/3043% above fair value
$270.56−2.64 (-0.97%)

Close on Nov 2, 2026Market cap $652.02BP/E 31.4Yield 1.90%

Johnson & Johnson Non-GAAP adjusted diluted net earnings per share by Quarter

Non-GAAP adjusted diluted net earnings per share ($) ($)

QuarterlyAnnual

Johnson & Johnson Non-GAAP adjusted diluted net earnings per share: $2.59 in Q3 2026, down 7.5% from a year earlier.

Latest, Q3 2026
2.59
Period ended Sep 30, 2026
Change on a year earlier
-7.5%
2.80 in Q3 2025
History
40 quarters
Since Q4 2016
Sources
36
Documents cited below

Where the Q3 2026 figure comes from

“|| Net earnings per share (Diluted) | $ | 2.59 | $ | 2.80 | (7.5)”

Source: Form 8-K (a2026q3exhibit991.htm, filed 2026-10-13) ↗

Reported in Form 8-K EX-99.2 Condensed Consolidated Statement of Earnings.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedNon-GAAP adjusted diluted net earnings per share ($) ($)Year on yearSource
Q3 2026Sep 30, 20262.59-7.5%Form 8-K (a2026q3exhibit991.htm, filed 2026-10-13) ↗
Q2 2026Jun 28, 20262.90+4.7%Form 8-K (a2026q2exhibit991.htm, filed 2026-07-15) ↗
Q1 2026Mar 29, 20262.70-2.5%Form 8-K (a2026q1exhibit991.htm, filed 2026-04-14) ↗
Q4 2025Dec 28, 20252.46+20.6%Form 8-K (a2025q4exhibit991.htm, filed 2026-01-21) ↗
Q3 2025Sep 28, 20252.80+15.7%Form 8-K (a2026q3exhibit991.htm, filed 2026-10-13) ↗
Q2 2025Jun 29, 20252.77-1.8%Form 8-K (a2026q2exhibit991.htm, filed 2026-07-15) ↗
Q1 2025Mar 30, 20252.77+2.2%Form 8-K (a2026q1exhibit991.htm, filed 2026-04-14) ↗
Q4 2024Dec 29, 20242.04-10.9%Form 8-K (a2025q4exhibit991.htm, filed 2026-01-21) ↗
Q3 2024Sep 29, 20242.42-9.0%Form 8-K (a2025q3exhibit991.htm, filed 2025-10-14) ↗
Q2 2024Jun 30, 20242.82+10.2%Form 8-K (a2025q2exhibit991.htm, filed 2025-07-16) ↗
Q1 2024Mar 31, 20242.71+12.4%Form 8-K (a2025q1exhibit991.htm, filed 2025-04-15) ↗
Q4 2023Dec 31, 20232.29+11.7%Form 8-K (a2024q4exhibit991.htm, filed 2025-01-22) ↗
Q3 2023Oct 1, 20232.66+19.3%Form 8-K (a2024q3exhibit991.htm, filed 2024-10-15) ↗
Q2 2023Jul 2, 20232.56-1.2%Form 8-K (a2024q2exhibit991.htm, filed 2024-07-17) ↗
Q1 2023Apr 2, 20232.41-9.7%Form 8-K (a2024q1exhibit991.htm, filed 2024-04-16) ↗
Q4 2022Jan 1, 20232.05-3.8%Form 8-K (a2023q4exhibit991.htm, filed 2024-01-23) ↗

Breakdown

What makes up non-GAAP adjusted diluted net earnings per share

Cite this data

StockData. (2026). Johnson & Johnson Non-GAAP adjusted diluted net earnings per share ($), quarterly Q4 2016–Q3 2026 [Data set]. Compiled from Johnson & Johnson SEC filings and investor materials. https://stockdatahq.com/stocks/jnj/kpis/adj-eps-diluted

See every metric in the Johnson & Johnson KPI table. Data updated Oct 25, 2026.